BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27918757)

  • 1. Outcome Measurement in Value-Based Payments.
    Mullangi S; Schleicher S; Feeley TW
    JAMA Oncol; 2017 Aug; 3(8):1019-1020. PubMed ID: 27918757
    [No Abstract]   [Full Text] [Related]  

  • 2. How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved?
    Schleicher SM; Wood NM; Lee S; Feeley TW
    Oncology (Williston Park); 2016 May; 30(5):468-74. PubMed ID: 27188679
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased requirements to avoid payment penalites in Quality Payment Program Year 3.
    Sales CM; Rathbun J; Woo K
    J Vasc Surg; 2019 Feb; 69(2):619. PubMed ID: 30683206
    [No Abstract]   [Full Text] [Related]  

  • 4. The Oncology Care Model and Other Value-Based Payment Models in Cancer Care.
    Aviki EM; Schleicher SM; Mullangi S
    JAMA Oncol; 2019 Mar; 5(3):298-299. PubMed ID: 30570655
    [No Abstract]   [Full Text] [Related]  

  • 5. Value-based Healthcare: A Novel Transitional Care Service Strives to Improve Patient Experience and Outcomes.
    Vetter TR; Uhler LM; Bozic KJ
    Clin Orthop Relat Res; 2017 Nov; 475(11):2638-2642. PubMed ID: 28840467
    [No Abstract]   [Full Text] [Related]  

  • 6. Shifting Landscape for Bundled Payments for Heart Conditions.
    Kuehn BM
    Circulation; 2018 Apr; 137(16):1740-1741. PubMed ID: 29661952
    [No Abstract]   [Full Text] [Related]  

  • 7. Current Policy and Practice for Value-Based Pricing.
    Augustovski F; McClellan MB
    Value Health; 2019 Jun; 22(6S):S4-S6. PubMed ID: 31200805
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing the Economic Challenges in the Treatment of Heart Failure.
    PiƱa IL; Desai NR; Allen LA; Heidenreich P
    Prog Cardiovasc Dis; 2018; 61(5-6):476-483. PubMed ID: 30565564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public Health Impact of the Centers for Medicare and Medicaid Services Decision on Pass-Through Add-On Payments for Drug-Coated Balloons: A Call to Action.
    Shishehbor MH; Jaff MR; Beckman JA; Misra S; Schneider PA; Lookstein R; Kashyap VS; Aronow HD; Jones WS; White CJ
    JACC Cardiovasc Interv; 2018 Mar; 11(5):496-499. PubMed ID: 29519384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Funding Cancer Quality Improvement: Payer's Perspective.
    Schumacher H
    J Oncol Pract; 2015 May; 11(3):180-1. PubMed ID: 25804984
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes to the end-stage renal disease quality incentive program.
    Fishbane S; Miller I; Wagner JD; Masani NN
    Kidney Int; 2012 Jun; 81(12):1167-71. PubMed ID: 22534963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value-based Healthcare: The Politics of Value-based Care and its Impact on Orthopaedic Surgery.
    Lin E; Sage WM; Bozic KJ; Jayakumar P
    Clin Orthop Relat Res; 2021 Apr; 479(4):674-678. PubMed ID: 33704105
    [No Abstract]   [Full Text] [Related]  

  • 13. Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence.
    Shishehbor MH; White CJ; Beckman JA; Misra S; Schneider PA; Lookstein RA; Kashyap VS; Clair D; Jones WS; Rosenfield K; Katzen BT; Jaff MR
    Vasc Med; 2018 Dec; 23(6):558-559. PubMed ID: 30238852
    [No Abstract]   [Full Text] [Related]  

  • 14. Does vascular surgery cost too much?
    Clagett GP
    J Vasc Surg; 2009 Nov; 50(5):1211-8. PubMed ID: 19782524
    [No Abstract]   [Full Text] [Related]  

  • 15. Use and impact of patient relationship modifiers on cost measurement.
    Larson RA; Johnson B; Woo K; Rathbun JA; Copeland TP
    J Vasc Surg; 2018 Jul; 68(1):307. PubMed ID: 29937035
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparing for the outpatient treatment of venous disease under MACRA.
    Leers SA; Woo K; Rathbun J; Johnson B
    J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):133. PubMed ID: 29248103
    [No Abstract]   [Full Text] [Related]  

  • 17. "Come Home": A Medicare Innovation Center project.
    McAneny BL
    Oncology (Williston Park); 2012 Dec; 26(12):1145, 1156. PubMed ID: 23413590
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced reimbursement for cardiovascular services by the Centers for Medicare and Medicaid Services: perspective from interventional cardiology.
    George JC; Popma JJ
    JACC Cardiovasc Interv; 2009 Sep; 2(9):894-6. PubMed ID: 19778781
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) meeting in July 2016 on chronic venous disease: An important first step.
    Lawrence PF
    J Vasc Surg Venous Lymphat Disord; 2017 May; 5(3):301-302. PubMed ID: 28411693
    [No Abstract]   [Full Text] [Related]  

  • 20. Data satisfaction: home health reps say there are no OASIS issues.
    Barr P
    Mod Healthc; 2012 Mar; 42(10):17. PubMed ID: 22458071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.